SYK

Stryker Corporation
$276.97
+1.57 (+0.57%)
Mkt Cap 106.18B
Volume 2,982,001
52W Range 267-392.55
Sector Healthcare
Beta 0.78
EPS (TTM) 9.73 USD
P/E Ratio 28.47
Revenue (TTM) 25.84B USD
Rev Growth (5Y) +11.8%
EPS Growth (5Y) +14.8%
AlphaVal · Fair Value
What we estimate one share is worth
$261.01
Overvalued weak signal
6.1% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
B
Platform & Compounding FCF
72.8 / 100 composite
A platform business that compounds free cash flow — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 25.12B 22.59B 20.50B 18.45B 17.11B 14.35B 14.88B 13.60B 12.44B 11.32B 9.95B 9.68B
Net Income 3.25B 2.99B 3.17B 2.36B 1.99B 1.60B 2.08B 3.55B 1.02B 1.65B 1.44B 515.00M
EPS 8.49 7.86 8.34 6.23 5.29 4.26 5.57 9.50 2.73 4.40 3.82 1.36
Free Cash Flow 4.28B 3.49B 3.14B 2.04B 2.74B 2.79B 1.54B 2.04B 961.00M 1.43B 629.00M 1.55B
FCF / Share 11.21 9.15 8.26 5.38 7.26 7.43 4.12 5.45 2.57 3.81 1.67 4.09
Operating CF 5.04B 4.24B 3.71B 2.62B 3.26B 3.28B 2.19B 2.61B 1.56B 1.92B 899.00M 1.78B
Total Assets 47.84B 42.97B 39.91B 36.88B 34.63B 34.33B 30.17B 27.23B 22.18B 20.43B 16.25B 17.71B
Total Debt 16.36B 14.12B 13.49B 13.53B 12.90B 14.43B 11.48B 9.86B 7.22B 6.91B 4.00B 3.97B
Cash & Equiv 4.01B 3.65B 2.97B 1.84B 2.94B 2.94B 4.34B 3.62B 2.54B 3.32B 3.38B 1.79B
Book Value 22.42B 20.63B 18.59B 16.62B 14.88B 13.08B 12.81B 11.73B 9.97B 9.55B 8.51B 8.60B
Return on Equity 0.14 0.15 0.17 0.14 0.13 0.12 0.16 0.30 0.10 0.17 0.17 0.06
SYK News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp. - SYK
Oct 08, 2026 06:00 AM · prnewswire.com
The Monopolistic Razor-and-Blade Engine I Can’t Stop Buying
Oct 08, 2026 03:15 AM · 247wallst.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp. - SYK
Oct 06, 2026 12:51 PM · globenewswire.com
Stryker (NYSE: SYK) lines up 2027 CEO handoff as Lobo becomes Executive Chair
Oct 06, 2026 05:02 AM · defenseworld.net
Stryker announces leadership succession
Oct 06, 2026 04:00 AM · globenewswire.com
Stryker: This Dividend Aristocrat Is Finally Cheap Again
Oct 05, 2026 03:30 AM · seekingalpha.com
SYK INVESTIGATION: Stryker Investors Should Contact Block & Leviton To Learn How They Might Recover Losses
Oct 02, 2026 12:26 PM · newsfilecorp.com
GEHC vs. SYK: Which Stock Should Value Investors Buy Now?
Oct 02, 2026 08:41 AM · zacks.com
Stryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSS
Oct 01, 2026 10:21 AM · prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp. - SYK
Oct 01, 2026 06:00 AM · prnewswire.com